Evidence map›Paper›PMID 38506067›Full record

ArticleJournal of cellular and molecular medicine2024

ApoE4 dysregulation incites depressive symptoms and mitochondrial impairments in mice.

Weifen Li, Tahir Ali, Kaiwu He, Chengyou Zheng, Ningning Li, Zhi-Jian Yu, Shupeng Li

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Defining the contributions of tau pathology in the amygdala to increasing depressive symptoms in aging.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Weifen LiDepartment of Infectious Diseases, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen University School of Medicine, Shenzhen, China.
Tahir AliState Key Laboratory of Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, China.
Kaiwu HeState Key Laboratory of Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, China.
Chengyou ZhengState Key Laboratory of Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, China.
Ningning LiTomas Lindahl Nobel Laureate Laboratory, Precision Medicine Research Centre, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Zhi-Jian YuDepartment of Infectious Diseases, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen University School of Medicine, Shenzhen, China.
Shupeng LiState Key Laboratory of Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, China.ORCID 0000-0002-7807-374X
Peking University · CNShenzhen University · CNCentre for Addiction and Mental Health · CASun Yat-sen University · CN

Funding

Grants Science and Technology Innovation Committee of Shenzhen JCYJ20170810163329510Guangdong Basic and Applied Basic Research Foundation 2022A1515010979National Natural Science Foundation of China 81902033National Natural Science Foundation of China 82002137Sanming Project of Medicine in Shenzhen SZSM201911003Science, Technology and Innovation Commission of Shenzhen Municipality of Basic Research Funds JCYJ20190809102219774Science, Technology and Innovation Commission of Shenzhen Municipality of Basic Research Funds JCYJ20190809110209389Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions 2019SHIBS0004Shenzhen Key Medical Discipline Construction Fund SZXK06162Shenzhen Nanshan District Major Scientific Research Program of the People's Republic of China NSZD2023019
6 · The paper itself

Abstract

Apolipoprotein E4 (ApoE4) is involved in the stress-response processes and is hypothesized to be a risk factor for depression by means of mitochondrial dysfunction. However, their exact roles and underlying mechanisms are largely unknown. ApoE4 transgenic mice (B6. Cg-ApoE

Indexed as

Apolipoprotein E4MelatoninAMP-Activated Protein KinasesAnimalsApolipoproteins EDepressionLipopolysaccharidesMiceMice, TransgenicMitochondriaProteomicsAMP-Activated Protein KinasesApolipoprotein E4Apolipoproteins ELipopolysaccharidesMelatoninApoE4depressionLPSmelatoninmitophagy

Identifiers

PMID38506067
PMCPMC10951871
OpenAlexW4393007231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.